ULTRALIFE CORP — Director's Dealing 2020

Apr 23, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ULTRALIFE CORP (ULBI)
CIK: 0000875657
Period of Report: 2020-04-22

Reporting Person: POPIELEC MICHAEL D (Director, Director, President and CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-04-22	Common Stock (Right to Buy)	$6.5062	A	40000	Acquired	2027-04-22	Common Stock (40000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock; $.10 par value	270288	Direct

Footnotes

F1: These options vest as follows: 13,334 shares on 04-22-2021; 13,333 shares on 04-22-2022 and 13,333 shares on 04-22-2023.